The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
BackgroundThere are currently no studies assessing effectiveness of sub‐dissociative intranasal (IN) ketamine as the initial analgesic for adult patients in the ED.
ObjectiveThe study aims to examine the effectiveness of sub‐dissociative IN ketamine as a primary analgesic agent for adult patients in the ED.
MethodThis is a prospective, observational study of adult ED patients presenting with severe...
Background: Intranasal (IN) fentanyl provides rapid and powerful non‐parenteral analgesia in the ED. A concentrated solution of fentanyl (300 µg/mL) has been used in prior trials, yet many ED use the standard solution at a concentration of 50 µg/mL, which is widely available and of low cost. We set out to determine if this lower concentration of fentanyl is also efficacious.
Methods: Prospective...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.